No connection

Search Results

OPK vs QDEL

OPK
OPKO Health, Inc.
BEARISH
Price
$1.18
Market Cap
$905.9M
Sector
Healthcare
AI Confidence
85%
QDEL
QuidelOrtho Corporation
BEARISH
Price
$12.71
Market Cap
$865.3M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
OPK
--
QDEL
--
Forward P/E
OPK
-3.58
QDEL
4.39
P/B Ratio
OPK
0.71
QDEL
0.45
P/S Ratio
OPK
1.49
QDEL
0.32
EV/EBITDA
OPK
-7.29
QDEL
6.32

Profitability

Gross Margin
OPK
13.5%
QDEL
46.81%
Operating Margin
OPK
-28.98%
QDEL
4.01%
Profit Margin
OPK
-37.19%
QDEL
-41.45%
ROE
OPK
-17.14%
QDEL
-46.15%
ROA
OPK
-6.62%
QDEL
1.27%

Growth

Revenue Growth
OPK
-19.2%
QDEL
2.2%
Earnings Growth
OPK
--
QDEL
--

Financial Health

Debt/Equity
OPK
0.31
QDEL
1.49
Current Ratio
OPK
3.97
QDEL
1.5
Quick Ratio
OPK
3.21
QDEL
0.77

Dividends

Dividend Yield
OPK
--
QDEL
--
Payout Ratio
OPK
0.0%
QDEL
0.0%

AI Verdict

OPK BEARISH

OPK exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in profitability and operational efficiency. While the company maintains a strong liquidity position with a current ratio of 3.97 and low debt, these are offset by a -19.2% decline in year-over-year revenue and deeply negative profit margins. The stock is trading below its book value (P/B 0.71), but the persistent long-term price decay (-72.8% over 5 years) suggests a value trap rather than a bargain. Despite optimistic analyst price targets, the deterministic data points to a company in structural decline.

Strengths
Strong short-term liquidity (Current Ratio 3.97)
Low leverage (Debt/Equity 0.31)
Trading at a discount to book value (P/B 0.71)
Risks
Severe operational weakness (Piotroski F-Score 1/9)
Significant revenue contraction (-19.2% YoY)
Deeply negative profit margins (-37.19%)
QDEL BEARISH

QuidelOrtho exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a technical trend score of 0/100. Despite appearing 'cheap' on a Price-to-Book (0.45) and Price-to-Sales (0.32) basis, the company suffers from negative profit margins (-41.45%) and a catastrophic 5-year price decline of 89.6%. The disconnect between the bullish analyst target ($30.83) and the deteriorating fundamental health suggests a classic value trap. The lack of revenue growth (2.2%) and negative ROE (-46.15%) further undermine any recovery thesis.

Strengths
Deeply undervalued Price-to-Book ratio (0.45)
Low Price-to-Sales ratio (0.32)
Strong Gross Margin (46.81%)
Risks
Critically low Piotroski F-Score (2/9) indicating fundamental weakness
Severe negative profit margins (-41.45%)
Extreme bearish price momentum (1Y change -49.5%, 6M change -54.8%)

Compare Another Pair

OPK vs QDEL: Head-to-Head Comparison

This page compares OPKO Health, Inc. (OPK) and QuidelOrtho Corporation (QDEL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile